4-Bromo-2-methyl-5-((2-oxopropyl)amino)pyridazin-3(2H)-one

Catalog No.: 
ACAIKY889
CAS No.: 
1956340-45-6
Molecular Formula: 
C8H10BrN3O2
Molecular Weight: 
260.09
4-Bromo-2-methyl-5-((2-oxopropyl)amino)pyridazin-3(2H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$1224.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Bromo-2-methyl-5-((2-oxopropyl)amino)pyridazin-3(2H)-one
IUPAC Name4-bromo-2-methyl-5-((2-oxopropyl)amino)pyridazin-3(2H)-one
Molecular FormulaC8H10BrN3O2
Molecular Weight260.09
SMILESO=C1C(Br)=C(NCC(C)=O)C=NN1C
InChI KeyPEMFUJFJWNKMRY-UHFFFAOYSA-N
Synonym4-BROMO-2-METHYL-5-((2-OXOPROPYL)AMINO)PYRIDAZIN-3(2H)-ONE;3(2H)-Pyridazinone, 4-bromo-2-methyl-5-[(2-oxopropyl)amino]-
CAS No.1956340-45-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACAIKY889 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPASM237 route compound structure diagram
    ACPASM2377737-17-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAIKY889 route product structure diagram
    ACAIKY8891956340-45-6
Inquiry

2. ACAIKY889 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPASM237 route compound structure diagram
    ACPASM2377737-17-9In Stock
  2. Plus
  3. ACPNJW680 route compound structure diagram
    ACPNJW68013645-74-4In Stock
  4. Then
  5. ACAIKY889 route product structure diagram
    ACAIKY8891956340-45-6
Inquiry

3. ACAIKY889 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACAIKY889 route product structure diagram
    ACAIKY8891956340-45-6
Inquiry

Comments (0)